First phase I trial of influenza A virus H1N1 vaccine in Singapore.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 13 May 2014

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Feb 2014 Status changed from active, no longer recruiting to completed.
29 Jan 2014 Results have been reported in a Cytos Biotechnology and Singapore Agency for Science, Technology and research media release.
29 Jan 2014 Primary endpoint 'Immunological-response' (Immunogenicity as demonstrated by seroconversion based on haemaglutination inhibition titres according to FDA criteria) has been met according a Cytos Biotechnology media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com